Clinical trials
General Anxiety Disorder clinical trials
Below are recruiting general anxiety disorder clinical trials, each written for real people, not researchers. We’re tracking 131 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05527509Recruiting
Study of risk and resilience in new RCMP cadets
This study follows people as they start RCMP Cadet Training to learn what factors affect “risk” and “resilience” (how well someone adapts under stress). It may help improve support for cadets during training.
Regina, SaskatchewanAges 19–57 - NCT07819773Recruiting
Device for treating generalized anxiety
This study tests a device that uses magnetic pulses to stimulate the brain, which may help reduce symptoms of generalized anxiety disorder (GAD). The treatment is non-invasive and does not require surgery.
Denver, ColoradoAges 22 years+ - NCT07807865RecruitingPhase 3
Testing a new anxiety medication for safety
This study is testing a new medication for generalized anxiety disorder. It will check if the drug is safe and well-tolerated when taken alone or alongside your current anxiety treatment.
Los Angeles, CaliforniaAges 18 years+ - NCT07798063Recruiting
Solution-focused therapy for generalized anxiety
This study tests a type of talk therapy called solution-focused therapy to help young adults with mild to moderate generalized anxiety. It may help you learn practical ways to manage anxiety and improve your well-being.
IslamabadAges 18–29 - NCT07767903RecruitingPhase 3
Study of a new medicine for generalized anxiety disorder
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
Redlands, CaliforniaAges 18 years+ - NCT07774481Recruiting
Anxiety skills study for Ohio residents
This study tests an anxiety management program that you can use on your smartphone. It aims to help reduce anxiety symptoms and improve daily functioning.
Columbus, OhioAges 18 years+ - NCT07770919Recruiting
Brain stimulation for generalized anxiety disorder
This study tests a non-invasive brain stimulation technique (called continuous theta burst stimulation) to see if it can reduce symptoms of generalized anxiety disorder. The treatment uses magnetic pulses to target areas of the brain involved in anxiety, and it may help if standard treatments haven't worked well.
Ho Chi Minh CityAges 18–65 - NCT07759128RecruitingPhase 3
Test of a new anxiety medication for adults with generalized anxiety disorder
This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.
Tucson, ArizonaAges 18 years+ - NCT07753330Recruiting
Anxiety treatment study
This study tests a new type of therapy that focuses on facing fears to help reduce anxiety. It may be a good fit if you have an anxiety disorder and are looking for treatment.
Santiago, Santiago MetropolitanAges 18–70 - NCT04221997RecruitingPhase 4
Sertraline study for anxious children and teens
This trial tests whether sertraline (an anti-anxiety medicine) helps children and teens with generalized, separation, and/or social anxiety disorders. It also includes healthy children/teens for comparison so researchers can better understand safety and symptoms over time.
Cincinnati, OhioAges 8–17 - NCT07604753Recruiting
Comparing two mental health screening questionnaires
This study compares two different questionnaires that doctors use to diagnose mental health conditions. Researchers want to check if a newer, shorter questionnaire works just as well as the longer standard one.
Hong KongAges 18 years+ - NCT07579897Recruiting
Group vs. Individual Therapy for Excessive Worry
This study tests whether therapy for generalized anxiety disorder (constant, hard-to-control worry) works better when done in a group or one-on-one. The therapy teaches you how to think differently about your worries to reduce anxiety.
Kristiansand, AgderAges 18 years+ - NCT05772104RecruitingPhase 3
Test a Chinese herbal capsule for generalized anxiety
This Phase 3 trial studies Shugan Jieyu Capsule to treat generalized anxiety disorder (GAD). It aims to see if it can reduce anxiety symptoms in people who fit specific anxiety severity and traditional diagnosis criteria.
BeijingAges 18–65 - NCT07489651RecruitingPhase 2
New treatment for generalized anxiety disorder
This trial tests a new medication called RE104 for people with generalized anxiety disorder (GAD). The goal is to see if it helps reduce anxiety symptoms safely.
Birmingham, AlabamaAges 18–74 - NCT07477990RecruitingPhase 3
Testing a digital device for anxiety treatment
This trial is testing a digital device called Aurora that helps treat moderate to severe anxiety. It compares the device to standard anxiety medications, so you may receive either the device or a pill. The goal is to see if the device can work as well as medication without the side effects.
Mexico City, Mexico CityAges 18–65 - NCT07478744RecruitingPhase 2
Study for generalized anxiety disorder with SYT-510
This trial tests a new medicine called SYT-510 for adults with generalized anxiety disorder who are not currently taking medication. It aims to see if the drug reduces anxiety and is safe.
LondonAges 18–55 - NCT07458100Recruiting
Step-by-step digital therapy for emotional disorders
This trial tests a digital stepped-care program for people with emotional disorders like depression, anxiety, OCD, PTSD, or eating disorders. It uses online tools to help manage symptoms, and you may access different levels of support based on your needs.
BeijingAges 18–65 - NCT07430800Recruiting
AI-Powered CBT for Anxiety in University Students
This study tests whether personalized computer models can improve cognitive behavioral therapy (a talk therapy that helps change thinking patterns) for anxiety. It's for university students who have mild to moderate anxiety and are comfortable with being recorded during sessions.
Los Angeles, CaliforniaAges 18 years+ - NCT07429578Recruiting
Brain stimulation for anxiety and insomnia
This study tests whether a gentle, non-invasive brain stimulation technique (tACS) can help people who have both generalized anxiety and long-term sleep problems. It aims to see if this treatment can reduce anxiety and improve sleep.
São Paulo, São PauloAges 18–65 - NCT07389473Recruiting
Studying eye movements in long-term psychiatric medication use (Gaize device)
This trial uses a special device (Gaize) to track how your eyes move while you take psychiatric medication. It aims to see how long-term medication affects eye patterns, which could help doctors better understand treatment responses.
Philadelphia, PennsylvaniaAges 18–65 - NCT07382323Recruiting
Comparing two talk therapies for anxiety and PTSD
This trial tests two types of therapy — metacognitive therapy and cognitive-behavioral therapy — to see which works better for people with certain anxiety disorders or PTSD. You would be randomly assigned to one of the treatments and attend regular sessions.
StockholmAges 18 years+ - NCT06811311Recruiting
Hypnotherapy and Brain Activity in Generalized Anxiety Disorder
This study uses EEG (a brain wave test) to see how Ericksonian hypnotherapy, a gentle type of hypnosis, affects brain activity and anxiety symptoms in people with Generalized Anxiety Disorder (GAD) who are not currently in treatment or taking medication for anxiety.
IstanbulAges 18–65 - NCT07330648RecruitingPhase 2
Crisugabalin for generalized anxiety disorder
This study tests a new investigational drug called crisugabalin for people with generalized anxiety disorder (GAD) who have not found enough relief from at least two other anxiety medications. The trial aims to see if crisugabalin can safely reduce anxiety symptoms.
Hefei, AnhuiAges 18 years+ - NCT07305701Recruiting
Study on Medical Students' Mental Health
This study follows first-year health students at the University of Orléans to understand their mental health over time. It aims to find ways to support students' well-being during their studies.
Orléans, LoiretAges 18 years+
Hear when a new General Anxiety Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general anxiety disorder?
- Yes. Clin2 currently lists 131 recruiting general anxiety disorder studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general anxiety disorder trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general anxiety disorder trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.